Spero Therapeutics, Inc.
SPRONASDAQHealthcare● Active
$2.81
+$0.07(+2.37%)
Market Cap$162413688
P/E Ratio—
52W High$3.22
52W Low$1.8
Spero Therapeutics, Inc.（SPRO）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · SPRO · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $8.57M | ($68.57M) | $22.81M | ($46.41M) | ($89.76M) |
| Depreciation & Amort. | $0.00M | $0.00M | $0.37M | $1.55M | $1.12M |
| Stock-Based Comp. | $4.33M | $7.79M | $7.93M | $0.00M | $0.00M |
| Change in Working Capital | ($27.16M) | $36.28M | ($70.38M) | $22.09M | $12.86M |
| Net Cash from Operations | ($12.62M) | ($23.44M) | ($32.99M) | ($7.73M) | ($64.35M) |
| Investing Activities | |||||
| Capital Expenditure | $0.00M | $0.00M | $0.00M | $0.00M | $64.35M |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | ($26.97M) | ($43.91M) |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $60.78M | $51.55M |
| Net Cash from Investing | $0.00M | $0.00M | $0.00M | $33.81M | $7.67M |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | ($54.48M) | $47.48M |
| Net Cash from Financing | $0.00M | $0.00M | $0.22M | ($29.55M) | $84.05M |
| Free Cash Flow | |||||
| Free Cash Flow | ($12.62M) | ($23.44M) | ($32.99M) | ($7.73M) | $0.00M |
| FCF Margin %(computed) | -21.17% | -48.87% | -31.79% | -15.91% | 0.00% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Spero Therapeutics, Inc.
关于Spero Therapeutics, Inc.（SPRO）现金流量表
Spero Therapeutics, Inc. 2025财年经营活动现金流($0.01B)，自由现金流($0.01B)（FCF利润率-21.17%），资本支出$0.00B。
常见问题
SPRO · 4 问Spero Therapeutics, Inc. 2025财年自由现金流($0.01B)，同比up46.2%。
SPRO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10